HN1L/AP-2γ/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma

Hematological and neurological expressed 1 like (HN1L) is a newly identified oncogene in lung cancer and hepatocellular carcinoma recently identified by our team, but its roles in the development and treatment of esophageal squamous cell carcinoma (ESCC) remain incompletely cataloged. Here, using ES...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Ting-Ting, Deng, Tian-Hao, Liu, Zhen, Zhan, Jia-Rong, Ma, Yuan-Zhen, Yan, Yuan-Yuan, Sun, Xiao, Zhu, Ying-Hui, Li, Yan, Guan, Xin-Yuan, Li, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729194/
https://www.ncbi.nlm.nih.gov/pubmed/36476988
http://dx.doi.org/10.1038/s41419-022-05478-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729194/
https://www.ncbi.nlm.nih.gov/pubmed/36476988
http://dx.doi.org/10.1038/s41419-022-05478-1

Ejemplares similares